Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
Kevin Y. Xu, Carrie M. Mintz, Ned Presnall, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2211363-e2211363
Open Access | Times Cited: 21

Showing 21 citing articles:

Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
Kevin Y. Xu, Jennifer K. Bello, Joanna Buss, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Polysubstance Use Is Not Synonymous With Poly Substance Use Disorder
Kevin Y. Xu, Lewei Lin, Richard A. Grucza
American Journal of Public Health (2025) Vol. 115, Iss. 5, pp. 646-648
Closed Access | Times Cited: 1
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Kevin Y. Xu, Alex K. Gertner, Shelly F. Greenfield, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 13
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
Ryan Cook, Canyon Foot, Onyebuchi A. Arah, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails
Elizabeth Flanagan, Lori J. Ducharme, Bruce G. Taylor, et al.
JAMA Network Open (2025) Vol. 8, Iss. 4, pp. e255340-e255340
Open Access
Substance-induced mental disorders and discontinuation of medication for opioid use disorder
Alyssa Shell Tilhou, Richard A. Grucza, Kevin Y. Xu
Drug and Alcohol Dependence (2025), pp. 112685-112685
Closed Access
First-hand accounts of structural stigma toward people who use opioids on Reddit
Evan L. Eschliman, Karen Choe, Alexandra DeLucia, et al.
Social Science & Medicine (2024) Vol. 347, pp. 116772-116772
Closed Access | Times Cited: 2
Evolution of the substance use landscape: Implications for contingency management
Shelby Goodwin, Kimberly C. Kirby, Bethany R. Raiff
Journal of Applied Behavior Analysis (2024) Vol. 58, Iss. 1, pp. 36-55
Open Access | Times Cited: 2
Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder Care
Alisa B. Busch, Alene Kennedy‐Hendricks, Cameron Schilling, et al.
Medical Care (2023) Vol. 61, Iss. 5, pp. 314-320
Open Access | Times Cited: 5
Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders
Madeline C. Frost, Carol A. Malte, Eric J. Hawkins, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 155, pp. 209175-209175
Open Access | Times Cited: 4
Contraceptive uptake in postpartum people with and without opioid use disorder and opioid use with co-occurring substance use
Jennifer K. Bello, Kevin Y. Xu, Joanne Salas, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100248-100248
Open Access | Times Cited: 1
Receipt of Medications for Opioid Use Disorder Among Rural and Urban Veterans Health Administration Patients
O.W. REYNOLDS, Kathleen F. Carlson, Adam J. Gordon, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 1
Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
Sean T. Allen, Kristin E. Schneider, Saba Rouhani, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 3
The role of polysubstance use on criminal justice involvement in the United States
Abenaa Jones, Sienna Strong-Jones, Hannah B. Apsley
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 290-300
Open Access | Times Cited: 2
Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
Zhenhao Shi, Daniel D. Langleben, David Rott, et al.
Journal of Addictive Diseases (2024) Vol. 43, Iss. 1, pp. 77-87
Closed Access
Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention
Majid Afshar, Emma J. Graham Linck, Alexandra B. Spicer, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 5, pp. 511-519
Closed Access
Postmortem toxicology findings from the Camden Opioid Research Initiative
Dara Kusic, Jessica Heil, Stefan Zajic, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0292674-e0292674
Open Access | Times Cited: 1
Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation
Claradina Soto, Kimberly A. Miller, Lou Moerner, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 155, pp. 209115-209115
Closed Access
Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics
Yuhui Zhu, Laura‐Mae Baldwin, Larissa J. Mooney, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 158, pp. 209269-209269
Closed Access
Management of Co-Occurring SUD and Chronic Pain
Gregory Rudolf
IntechOpen eBooks (2022)
Open Access
Page 1

Scroll to top